Abstract
Members of all four families of ectonucleotidases, namely ectonucleoside triphosphate diphosphohydrolases (NTPDases), ectonucleotide pyrophosphatase/phosphodiesterases (NPPs), ecto-5′-nucleotidase and alkaline phosphatases, have been identified in the renal vasculature and/or tubular structures. In rats and mice, NTPDase1, which hydrolyses ATP through to AMP, is prominent throughout most of the renal vasculature and is also present in the thin ascending limb of Henle and medullary collecting duct. NTPDase2 and NTPDase3, which both prefer ATP over ADP as a substrate, are found in most nephron segments beyond the proximal tubule. NPPs catalyse not only the hydrolysis of ATP and ADP, but also of diadenosine polyphosphates. NPP1 has been identified in proximal and distal tubules of the mouse, while NPP3 is expressed in the rat glomerulus and pars recta, but not in more distal segments. Ecto-5′-nucleotidase, which catalyses the conversion of AMP to adenosine, is found in apical membranes of rat proximal convoluted tubule and intercalated cells of the distal nephron, as well as in the peritubular space. Finally, an alkaline phosphatase, which can theoretically catalyse the entire hydrolysis chain from nucleoside triphosphate to nucleoside, has been identified in apical membranes of rat proximal tubules; however, this enzyme exhibits relatively high K m values for adenine nucleotides. Although information on renal ectonucleotidases is still incomplete, the enzymes’ varied distribution in the vasculature and along the nephron suggests that they can profoundly influence purinoceptor activity through the hydrolysis, and generation, of agonists of the various purinoceptor subtypes. This review provides an update on renal ectonucleotidases and speculates on the functional significance of these enzymes in terms of glomerular and tubular physiology and pathophysiology.
Similar content being viewed by others
References
Schwiebert EM, Kishore BK (2001) Extracellular nucleotide signaling along the renal epithelium. Am J Physiol Renal Physiol 280:F945–F963
Vekaria RM, Unwin RJ, Shirley DG (2006) Intraluminal ATP concentrations in rat renal tubules. J Am Soc Nephrol 17:1841–1847
Lazarowski ER, Boucher RC, Harden TK (2000) Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J Biol Chem 275:31061–31068
Yegutkin GG (2008) Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signaling cascade. Biochim Biophys Acta 1783:673–694
Kimura N, Shimada N, Nomura K, Watanabe K (1990) Isolation and characterization of a cDNA clone encoding rat nucleoside diphosphate kinase. J Biol Chem 265:15744–15749
Cole BR, Hays AE, Boylan JG, Burch HB, Lowry OH (1982) Distribution of enzymes of adenylate and guanylate nucleotide metabolism in rat nephron. Am J Physiol 243:F349–F355
Praetorius HA, Leipziger J (2009) ATP release from non-excitable cells. Pur Sig in press
Zimmermann H (2001) Ecto-nucleotidases. In: Abbracchio MP, Williams M (eds) Purinergic and pyrimidinergic signalling. Handbook of experimental pharmacology, vol 151. Springer-Verlag, Berlin, pp 209–250
Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Nuanyn Schmiedebergs Arch Pharmacol 362:299–309
Kukulski F, Lévesque SA, Lavoie EG et al (2005) Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Pur Sig 1:193–204
Laliberté JF, Beaudoin AR (1983) Sequential hydrolysis of the gamma- and beta-phosphate groups of ATP by the ATP diphosphohydrolase from pig pancreas. Biochim Biophys Acta 742:9–15
Robson SC, Sévigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Pur Sig 2:409–430
Bigonnesse F, Lévesque SA, Kukulski F et al (2004) Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry 43:5511–5519
Fausther M, Lecka J, Kukulski F et al (2007) Cloning, purification and identification of the liver canalicular ecto-ATPase as NTPDase8. Am J Physiol Gastrointest Liver Physiol 292:G785–G795
Stefan C, Jansen S, Bollen M (2006) Modulation of purinergic signalling by NPP-type ectophosphodiesterases. Pur Sig 2:361–370
Gijsbers R, Aoki J, Arai H, Bollen M (2003) The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site. FEBS Lett 538:60–64
Lévesque SA, Lavoie EG, Lecka J et al (2007) Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br J Pharmacol 152:141–150
Millán JL (2006) Alkaline phosphatases. Pur Sig 2:335–341
Ohkubo S, Kimura J, Matsuoka I (2000) Ecto-alkaline phosphatase in NG108–15 cells: a key enzyme mediating P1 antagonist-sensitive ATP response. Br J Pharmacol 131:1667–1672
Picher M, Burch LH, Hirsh AJ et al (2003) Ecto 5'-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J Biol Chem 278:13468–13479
Sévigny J, Robson SC, Waelkens E et al (2000) Identification and characterization of a novel hepatic canalicular ATP diphosphohydrolase. J Biol Chem 275:5640–5647
Kishore BK, Isaac J, Fausther M et al (2005) Expression of NTPDase1 and NTPDase2 in murine kidney: relevance to regulation of P2 receptor signaling. Am J Physiol Renal Physiol 288:F1032–F1043
Vekaria RM, Shirley DG, Sévigny J, Unwin RJ (2006) Immunolocalization of ectonucleotidases along the rat nephron. Am J Physiol Renal Physiol 290:F550–F560
Lemmens R, Kupers L, Sévigny J et al (2000) Purification, characterization, and localization of an ATP diphosphohydrolase in porcine kidney. Am J Physiol Renal Physiol 278:F978–F988
Harahap AR, Goding JW (1988) Distribution of the murine plasma cell antigen PC-1 in non-lymphoid tissues. J Immunol 141:2317–2320
Colgan SP, Eltzschig HK, Eckle T, Thompson LF (2006) Physiological roles for ecto-5′-nucleotidase (CD73). Pur Sig 2:351–360
Gandhi R, Le Hir M, Kaissling B (1990) Immunolocalization of ecto-5′-nucleotidase in the kidney by a monoclonal antibody. Histochemistry 95:165–174
Le Hir M, Kaissling B (1989) Distribution of 5′-nucleotidase in the renal interstitium of the rat. Cell Tissue Res 258:177–182
Le Hir M, Kaissling B (1993) Distribution and regulation of renal ecto-5′-nucleotidase: implications for physiological functions of adenosine. Am J Physiol Renal Fluid Electrolyte Physiol 264:F377–F387
Beliveau R, Brunette MG, Strevey J (1983) Characterization of phosphate binding by alkaline phosphatase in rat kidney brush border membrane. Pflügers Arch 398:227–232
Kaczmarek E, Koziak K, Sévigny J et al (1996) Identification and characterization of CD39 vascular ATP diphosphohydrolase. J Biol Chem 271:33116–33122
Enjyoji K, Sévigny J, Lin Y et al (1999) Targeted disruption of CD39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010–1017
Inscho EW (2009) ATP, P2 receptors and the renal microcirculation. Pur Sig in press
Flores NA, Stavrou BM, Sheridan DJ (1999) The effects of diadenosine polyphosphates on the cardiovascular system. Cardiovasc Res 42:15–26
Jankowski M, Szczepanska-Konkel M, Kalinowski L, Angielski S (2001) The role of P2Y-receptors in the regulation of glomerular volume. Med Sci Monit 7:635–640
Harada H, Chan CM, Loesch A, Unwin R, Burnstock G (2000) Induction of proliferation and apoptotic cell death via P2Y and P2X receptors, respectively, in rat glomerular mesangial cells. Kidney Int 57:949–958
Bell PD, Komlosi P, Zhang Z-R (2009) ATP as a mediator of macula densa cell signaling. Pur Sig in press
Schnermann J (2003) The juxtaglomerular apparatus: from anatomical peculiarity to physiological relevance. J Am Soc Nephrol 14:1681–1694
Nishiyama A, Majid DS, Walker M et al (2001) Renal interstitial ATP responses to changes in arterial pressure during alterations in tubuloglomerular feedback activity. Hypertension 37:753–759
Inscho EW, Cook AK, Imig JD et al (2003) Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Invest 112:1895–1905
Osswald H, Muhlbauer B, Schenk F (1991) Adenosine mediates tubuloglomerular feedback response: an element of metabolic control of kidney function. Kidney Int Suppl 32:S128–S131
Sun D, Samuelson LC, Yang T et al (2001) Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci USA 98:9983–9988
Castrop H, Huang Y, Hashimoto S et al (2004) Impairment of tubuloglomerular feedback regulation of GFR in ecto-5′-nucleotide/CD73-deficient mice. J Clin Invest 114:634–642
Huang DY, Vallon V, Zimmermann H et al (2006) Ecto-5′-nucleotidase (cd73)-dependent and –independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo. Am J Physiol Renal Physiol 291:F282–F288
Smith JA, Sivaprasadarao A, Munsey TS (2001) Immunolocalisation of adenosine A1 receptors in the rat kidney. Biochem Pharmacol 61:237–244
Wilcox CS, Welch WJ, Schreiner GF, Belardinelli L (1999) Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist. J Am Soc Nephrol 10:714–720
Mangravite LM, Xiao G, Giacomini KM (2003) Localization of human equilibrative nucleoside transporters, hENT1 and hANT2, in renal epithelial cells. Am J Physiol Renal Physiol 284:F902–F910
Bailey MA, Shirley DG (2009) Effects of extracellular nucleotides on renal tubular solute transport. Pur Sig in press
Kishore BK, Nelson RD, Miller RL et al (2009) P2Y2 receptors and water transport in the kidney. Pur Sig in press
Yagil C, Katni G, Yagil Y (1994) The effects of adenosine on transepithelial resistance and sodium uptake in the inner medullary collecting duct. Pflügers Arch 427:225–232
Jackson EK, Mi Z, Zhu C, Dubey RK (2003) Adenosine biosynthesis in the collecting duct. J Pharmacol Exp Ther 307:888–896
Poelstra K, Heynen ER, Baller JF et al (1992) Modulation of anti-Thy1 nephritis in the rat by adenine nucleotides. Evidence for an anti-inflammatory role for nucleotidases. Lab Invest 66:555–563
Canani LH, Ng DP, Smiles A et al (2002) Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes. Diabetes 51:1188–1193
De Cosmo S, Trevisan R, Dalla Vestra M et al (2003) PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates. Diabetes Care 26:2898–2902
Friedman DJ, Rennke HG, Csizmadia E et al (2007) The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy. Diabetes 56:2371–2379
Imai M, Takigami K, Guckelberger O et al (1999) Modulation of nucleoside triphosphate diphosphohydrolase-1 (NTPDase-1) cd39 in xenograft rejection. Mol Med 5:743–752
Mui KW, van Son WJ, Tiebosch TMG et al (2003) Clinical relevance of immunohistochemical staining for ecto-AMPase and ecto-ATPase in chronic allograft nephropathy (CAN). Nephrol Dial Transplant 18:153–163
Smit-van Oosten A, Bakker WW, van Goor H (2002) De-novo expression of vascular ecto-5′-nucleotidase and down-regulation of glomerular ecto-ATPase in experimental chronic renal transplant failure. Transpl Int 15:602–609
Candinas D, Koyamada N, Miyatake T et al (1996) Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions. Thromb Haemost 76:807–812
Grenz A, Zhang H, Hermes M et al (2007) Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J 21:2863–2873
Bakker WW, Mui KW, van Son WJ (2000) Detection of glomerular ischemia in chronic graft failure by the quantification of glomerular ecto 5′nucleotidase and ecto-ATPase. In: Vanduffel, Lemmens (ed) Ecto-ATPase and related ectonucleotidases. Shaker Publishers, Maastricht, pp 192–201
Kaissling B, Speiss S, Rinne B, Le Hir M (1993) Effects of anemia on morphology of rat renal cortex. Am J Physiol 264:F608–F617
Grenz A, Zhang H, Eckle T et al (2007) Protective role of ecto-5′-nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol 18:833–845
Okusa MD (2002) A2A adenosine receptor: a novel therapeutic target in renal disease. Am J Physiol Renal Physiol 282:F10–F18
Zhao Z, Kapoian T, Shepard M, Lianos EA (2002) Adenosine-induced apoptosis in glomerular mesangial cells. Kidney Int 61:1276–1285
Munkonda MN, Kauffenstein G, Kukulski F et al (2007) Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists. Biochem Pharmacol 74:1524–1534
Grobben B, Claes P, Roymans D et al (2000) Ecto-nucleotide pyrophosphatase modulates the purinoceptor-mediated signal transduction and is inhibited by purinoceptor antagonists. Br J Pharmacol 130:139–145
Iqbal J, Vollmayer P, Braun N et al (2005) A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction. Pur Sig 1:349–358
Gendron FP, Halbfinger E, Fischer B et al (2000) Novel inhibitors of nucleoside triphosphate diphosphohydrolases: chemical synthesis and biochemical and pharmacological characterizations. J Med Chem 43:2239–2247
Gendron FP, Benrezzak O, Krugh BW et al (2002) Purine signaling and potential new therapeutic approach: possible outcomes of NTPDase inhibition. Curr Drug Targets 3:229–245
Müller CE, Iqbal J, Bagi Y et al (2006) Polyoxometalates—a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorg Med Chem Lett 16:5943–5947
Brunschweiger A, Iqbal J, Umbach F et al (2008) Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleoside mimetics derived from uridine-5′-carboxamide. J Med Chem 51:4518–4528
Munkonda MN, Pelletier J, Ivanenkov VV et al (2009) Characterization of a monoclonal antibody as the first specific inhibitor of human nucleoside triphosphate diphosphohydrolase-3 (NTPDase3): partial characterization of the inhibitory epitope and potential applications. FEBS J 276:479–96
Knowles AE, Nagy AK (1999) Inhibition of an ecto-ATP-diphosphohydrolase by azide. Eur J Biochem 262:349–357
Plesner L (1995) Ecto-ATPases: identities and functions. Int Rev Cytol 158:141–214
Enjyoji K, Sévigny J, Lin Y et al (1999) Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010–1017
Cauwenberghs S, Feijge MA, Hageman G et al (2006) Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation. Transfusion 46:1018–1028
Schaefer U, Machida T, Broekman MJ et al (2007) Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors. J Pharmacol Exp Ther 322:1269–1277
Leipziger J (2003) Control of epithelial transport via luminal P2 receptors. Am J Physiol Renal Physiol 284:F419–F432
Acknowledgements
Work in the authors’ laboratories was supported by Kidney Research UK, St Peter’s Trust for Kidney, Bladder and Prostate Research and the Canadian Institutes of Health Research (CIHR). J.S. was also the recipient of a New Investigator award from the CIHR.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shirley, D.G., Vekaria, R.M. & Sévigny, J. Ectonucleotidases in the kidney. Purinergic Signalling 5, 501–511 (2009). https://doi.org/10.1007/s11302-009-9152-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-009-9152-4